Total Payments
$1,645
2024 Payments
$183.99
Companies
13
Transactions
60
Medicare Patients
12,174
Medicare Billing
$9.0M
Payment Breakdown by Category
Food & Beverage$1,610 (97.8%)
Education$35.37 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,610 | 58 | 97.8% |
| Education | $35.37 | 2 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $278.17 | 12 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $242.91 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $229.72 | 6 | $0 (2021) |
| Alimera Sciences, Inc. | $198.18 | 12 | $0 (2020) |
| Genentech, Inc. | $184.82 | 3 | $0 (2020) |
| Alcon Vision LLC | $183.73 | 2 | $0 (2023) |
| Alcon Laboratories Inc | $144.80 | 2 | $0 (2018) |
| Astellas Pharma US Inc | $55.83 | 3 | $0 (2024) |
| ABBVIE INC. | $42.56 | 2 | $0 (2023) |
| Allergan Inc. | $31.66 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $183.99 | 9 | Regeneron Healthcare Solutions, Inc. ($85.16) |
| 2023 | $283.17 | 6 | Alcon Vision LLC ($166.91) |
| 2022 | $94.86 | 8 | Regeneron Healthcare Solutions, Inc. ($39.28) |
| 2021 | $42.06 | 3 | Genentech USA, Inc. ($15.28) |
| 2020 | $195.68 | 5 | Novartis Pharmaceuticals Corporation ($126.19) |
| 2019 | $238.73 | 9 | Novartis Pharmaceuticals Corporation ($92.00) |
| 2018 | $384.40 | 10 | Alcon Laboratories Inc ($144.80) |
| 2017 | $222.21 | 10 | Genentech USA, Inc. ($119.12) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: OPTOMETRY | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Ophthalmology | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Ophthalmology | ||||||
| 04/02/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Ophthalmology | ||||||
| 03/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Education | In-kind items and services | $17.19 | General |
| Category: Ophthalmology | ||||||
| 10/05/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/18/2023 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $166.91 | General |
| Category: Ophthalmology | ||||||
| 08/31/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/06/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/23/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/16/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: EYE CARE | ||||||
| 11/28/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: RETINA | ||||||
| 11/02/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/03/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/21/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/21/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/21/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $0.57 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/17/2022 | Genentech USA, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/17/2022 | Genentech USA, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $1.24 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/15/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/17/2021 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 3,390 | 30,459 | $7.7M | $2.5M |
| 2022 | 13 | 3,381 | 11,925 | $7.0M | $2.5M |
| 2021 | 12 | 2,802 | 9,747 | $5.8M | $2.3M |
| 2020 | 12 | 2,601 | 8,411 | $4.6M | $1.8M |
Total Patients
12,174
Total Services
60,542
Medicare Billing
$9.0M
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 228 | 2,071 | $3.0M | $1.5M | 51.0% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2021 | 24 | 870 | $356,153 | $189,381 | 53.2% |
| 67028 | Injection of drug into eye | Office | 2021 | 467 | 1,834 | $1.1M | $181,029 | 16.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2021 | 28 | 511 | $363,200 | $129,048 | 35.5% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 866 | 2,506 | $490,820 | $79,545 | 16.2% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2021 | 198 | 810 | $84,998 | $45,661 | 53.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 425 | 431 | $172,310 | $40,352 | 23.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 369 | 511 | $142,131 | $34,787 | 24.5% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 106 | 106 | $49,457 | $12,811 | 25.9% |
| 67145 | Preventive retinal detachment treatment by heat or laser, 1 or more sessions | Office | 2021 | 11 | 12 | $19,920 | $5,405 | 27.1% |
| 92250 | Photography of the retina | Office | 2021 | 61 | 64 | $20,335 | $1,655 | 8.1% |
| 76512 | Ultrasound of eye disease, growth, or structure | Office | 2021 | 19 | 21 | $5,513 | $678.64 | 12.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2020 | 192 | 1,533 | $2.1M | $1.1M | 54.7% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2020 | 35 | 1,020 | $387,205 | $199,295 | 51.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2020 | 31 | 553 | $397,940 | $148,108 | 37.2% |
| 67028 | Injection of drug into eye | Office | 2020 | 426 | 1,435 | $870,500 | $129,735 | 14.9% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 793 | 2,173 | $410,040 | $66,631 | 16.2% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2020 | 192 | 628 | $63,840 | $38,276 | 60.0% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 413 | 541 | $141,734 | $35,978 | 25.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 320 | 323 | $126,300 | $31,518 | 25.0% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 92 | 92 | $42,667 | $10,668 | 25.0% |
| 67145 | Preventive retinal detachment treatment by heat or laser, 1 or more sessions | Office | 2020 | 19 | 19 | $29,974 | $8,410 | 28.1% |
| 92250 | Photography of the retina | Office | 2020 | 73 | 79 | $25,520 | $2,625 | 10.3% |
| 76512 | Ultrasound of eye disease, growth, or structure | Office | 2020 | 15 | 15 | $4,470 | $702.22 | 15.7% |
About Dr. Bryan Hong, M.D
Dr. Bryan Hong, M.D is a Retina Specialist healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1306166756.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Hong, M.D has received a total of $1,645 in payments from pharmaceutical and medical device companies, with $183.99 received in 2024. These payments were reported across 60 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,610).
As a Medicare-enrolled provider, Hong has provided services to 12,174 Medicare beneficiaries, totaling 60,542 services with total Medicare billing of $9.0M. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Worcester, MA
- Active Since 06/08/2010
- Last Updated 04/12/2017
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1306166756
Products in Payments
- Lucentis (Biological) $274.35
- Constellation (Device) $199.37
- BEOVU (Drug) $166.30
- EYLEA HD (Biological) $112.50
- Non-Covered Product (Drug) $99.54
- EYLEA (Biological) $85.55
- Iluvien (Drug) $84.73
- OZURDEX (Drug) $74.22
- Izervay (Drug) $55.83
- Vabysmo (Drug) $54.41
- EYLEA AFLIBERCEPT INJECTION (Biological) $44.86
- IHEEZO (Drug) $25.81
- SUSVIMO (Drug) $20.41
- Syfovre (Drug) $17.19
- ARZERRA (Drug) $14.35
- VABYSMO (Drug) $14.28
- Iluvien (Biological) $13.80
- P200DTx (Device) $9.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.